Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01594476 · ClinicalTrials.gov registry record · Phase 4
Early Postpartum Intrauterine Device (IUD) Placement
A Phase 4 study, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 201
- Enrollment target
NCT01594476 is a Phase 4 study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 201 participants.
The verdict
NCT01594476, a Phase 4 study, was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 201 participants
- Enrollment target
Study Summary
Women who have just given birth are at high risk for rapid repeat pregnancy, which can lead to negative consequences during the subsequent pregnancy. Providers have traditionally delayed starting birth control, especially placement of intrauterine devices (IUDs), post-delivery for a number of reasons. The first postpartum visit after a woman has given birth is typically scheduled for 6 weeks after her delivery, during which she is typically provided with her chosen method of birth control. This study will evaluate two different IUD placement times: 3 weeks and 6 weeks after delivery. This will allow the researchers to determine if placement time affects a woman's follow-through obtaining the IUD and keeping it inserted in place. The researchers will also look at bleeding patterns and patient/provider satisfaction with the IUD placement
Interventions
- DRUG Levonorgestrel IUS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01594476
The ClinicalTrials.gov registry entry for NCT01594476 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Levonorgestrel IUS is the first listed.
NCT01594476 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01594476 about?
NCT01594476 is a clinical study titled "Early Postpartum Intrauterine Device (IUD) Placement". Women who have just given birth are at high risk for rapid repeat pregnancy, which can lead to negative consequences during the subsequent pregnancy. Providers have traditionally delayed starting birth control, especially placement of intrauterine devices (IUDs), post-delivery for a number of reason...
What is the current status of trial NCT01594476?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 201 participants. The study started on 2012-03. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01594476?
The interventions under investigation include: Levonorgestrel IUS (DRUG).
Who is sponsoring clinical trial NCT01594476?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.